The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

SureCN1041165     methyl4-[4-[4-(7,9,9-trioxo- 9$l^{6}-thia...

Synonyms: SDZ-216525, Sdz-216-525, PDSP1_000565, PDSP2_000563, SDZ 216,525, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Psychiatry related information on Sdz 216-525

 

High impact information on Sdz 216-525

  • A lack of specificity of NAN-190 (and possibly SDZ 216-525) at high doses may explain the failure of previous studies to detect a 5-HT1A receptor agonist action [2].
  • Effect of the putative 5-HT1A antagonists WAY100135 and SDZ 216-525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus [3].
  • These values compared favorably with those of the structurally related eltoprazine (8.0) and the proposed 5-HT1A antagonists NAN-190 (9.2), MDL 73005 EF (8.9), SDZ 216-525 (8.8), BMY 7378 (8.7), (-)-tertatolol (8.1), (-)-alprenolol (7.7), WAY 100,135 (7.5) and spiperone (6.9) [4].
  • In addition, the effects of 8-OH-DPAT were blocked by a 5-HT1A antagonist, SDZ 216-525 [5].
  • In radioligand binding studies, SDZ 216-525 showed high affinity and selectivity for 5-HT1A sites (pKD = 9.2) as compared to 5-HT1B, 5-HT1C, 5-HT1D, 5-HT2 and 5-HT3 sites (pKD = 6.0, 7.2, 7.5, 5.2 and 5.4, respectively) [6].
 

Chemical compound and disease context of Sdz 216-525

 

Biological context of Sdz 216-525

 

Anatomical context of Sdz 216-525

 

Associations of Sdz 216-525 with other chemical compounds

  • The pharmacological properties of SDZ 216-525, methyl 4-(4-[4-(1,1,3-trioxo-2H-1,2-benzoisothiazol-2-yl)butyl]-1-p iperazinyl)1H- indole-2-carboxylate, a new selective and potent 5-HT1A receptor antagonist, are described in vitro (and comparisons made with those of MDL 73005 and NAN 190, two putative 5-HT1A receptor antagonists) and in vivo [6].
  • This effect was blocked by ritanserin, a 5-HT2/7 receptor antagonist, but not by SDZ-216-525, a 5-HT1A antagonist [10].
 

Gene context of Sdz 216-525

  • The novel 5-HT1A antagonists, WAY 100,135, MDL 73005 EF and (very potently) SDZ 216-525 all blocked DIH [11].
  • SDZ 216-525 (0.025-1.0 mg/kg), a selective 5-HT1A antagonist, significantly attenuated offensive posturing and bite-attacks at 1.0 mg/kg, and all offensive behaviors nonsignificantly at the smaller doses tested [1].

References

  1. Effects of (-)-pindolol and SDZ 216-525 on social and agonistic behavior in mice. Bell, R., Hobson, H. Pharmacol. Biochem. Behav. (1993) [Pubmed]
  2. The role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release--II NAN-190 and SDZ 216-525. Sharp, T., Umbers, V., Hjorth, S. Neuropharmacology (1996) [Pubmed]
  3. Effect of the putative 5-HT1A antagonists WAY100135 and SDZ 216-525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus. Mundey, M.K., Fletcher, A., Marsden, C.A. Neuropharmacology (1994) [Pubmed]
  4. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists. Millan, M.J., Canton, H., Gobert, A., Lejeune, F., Rivet, J.M., Bervoets, K., Brocco, M., Widdowson, P., Mennini, T., Audinot, V. J. Pharmacol. Exp. Ther. (1994) [Pubmed]
  5. Effects of serotonergic agonists on firing rates of photically responsive cells in the hamster suprachiasmatic nucleus. Ying, S.W., Rusak, B. Brain Res. (1994) [Pubmed]
  6. SDZ 216-525, a selective and potent 5-HT1A receptor antagonist. Schoeffter, P., Fozard, J.R., Stoll, A., Siegl, H., Seiler, M.P., Hoyer, D. Eur. J. Pharmacol. (1993) [Pubmed]
  7. Lack of effect of the 5-HT(1A) receptor antagonist WAY-100635 on murine agonistic behaviour. Bell, R., Lynch, K., Mitchell, P. Pharmacol. Biochem. Behav. (1999) [Pubmed]
  8. SDZ 216-525, a selective 5-HT1A receptor antagonist, reverts zinc-induced inhibition of water intake in dehydrated rats. Fregoneze, J.B., Ferreira, H., Soares, T., Luz, C.P., Bulcão, C., Nascimento, T., Marinho, C.A., Sarmento, C., De-Oliveira, I.R., Cunha, M. Braz. J. Med. Biol. Res. (1995) [Pubmed]
  9. The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo. Sharp, T., McQuade, R., Fozard, J.R., Hoyer, D. Br. J. Pharmacol. (1993) [Pubmed]
  10. Serotonin directly stimulates luteinizing hormone-releasing hormone release from GT1 cells via 5-HT7 receptors. Héry, M., François-Bellan, A.M., Héry, F., Deprez, P., Becquet, D. Endocrine (1997) [Pubmed]
  11. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists. Millan, M.J., Rivet, J.M., Canton, H., Le Marouille-Girardon, S., Gobert, A. J. Pharmacol. Exp. Ther. (1993) [Pubmed]
 
WikiGenes - Universities